Literature DB >> 26031572

Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.

Erin Moses1, Heather N Pedersen2, Sheona M Mitchell2, Musa Sekikubo3, David Mwesigwa4, Joel Singer2, Christine Biryabarema3, Josaphat K Byamugisha3, Deborah M Money1,2, Gina S Ogilvie1,2.   

Abstract

OBJECTIVES: To compare two cervical cancer screening methods: community-based self-collection of high-risk human papillomavirus (HR-HPV) testing and visual inspection with acetic acid (VIA).
METHODS: Pilot randomised controlled trial of 500 women aged 30-65 in the community of Kisenyi, Uganda. Women randomised to self-collection-based HR-HPV testing provided a cervico-vaginal swab for HR-HPV, and results were provided by phone after laboratory testing. Women who tested HPV positive were referred for VIA at the local health unit. Women randomised to VIA underwent screening at the local health unit, where women who tested positive with VIA were provided cryotherapy at time of screening, as per local standard of care. Women were referred for colposcopy when indicated. Outcome measures were uptake of screening, HR-HPV prevalence, VIA result and treatment rates.
RESULTS: In the HR-HPV arm, 248 of 250 (p < 0.01) women provided samples, while in the VIA arm, 121 of 250 (48.4%) women attended screening. Among the 73 of 248 HR-HPV-positive women, 45.2% (N = 33) attended VIA screening for follow-up, 21.2% (N = 7) of whom screened positive; five received treatment and two were missing clinical follow-up records. Of the 121 women in the VIA arm who attended screening, 13.2% (N = 16) screened positive; seven received cryotherapy, three refused treatment, five were referred to colposcopy; and one woman had suspected cervical cancer and received treatment after confirmatory testing.
CONCLUSIONS: This pilot study demonstrated trial feasibility and willingness of the women to participate and be randomised successfully into the two arms. Self-collection-based cervical cancer screening had a higher uptake than VIA.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  auto-collection; autorecolección; cancer du col utérin; cervical cancer; communautaire; community based; comunitario; cribado; cáncer cervical; dépistage; human papillomavirus; papillomavirus humain; screening; self-collection; virus del papiloma humano

Mesh:

Substances:

Year:  2015        PMID: 26031572     DOI: 10.1111/tmi.12549

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  32 in total

1.  HPV self-sampling acceptability and preferences among women living with HIV in Botswana.

Authors:  Racquel E Kohler; Tamara Elliott; Barati Monare; Neo Moshashane; Kehumile Ramontshonyana; Pritha Chatterjee; Doreen Ramogola-Masire; Chelsea Morroni
Journal:  Int J Gynaecol Obstet       Date:  2019-10-02       Impact factor: 3.561

2.  Cost-effectiveness studies of HPV self-sampling: A systematic review.

Authors:  Colin Malone; Ruanne V Barnabas; Diana S M Buist; Jasmin A Tiro; Rachel L Winer
Journal:  Prev Med       Date:  2020-01-03       Impact factor: 4.018

3.  Sexual and reproductive health and human rights of women living with HIV.

Authors:  Manjulaa Narasimhan; Mona Loutfy; Rajat Khosla; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-01       Impact factor: 5.396

4.  Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.

Authors:  Chemtai Mungo; Saduma Ibrahim; Elizabeth A Bukusi; Hong-Ha M Truong; Craig R Cohen; Megan Huchko
Journal:  Int J Gynaecol Obstet       Date:  2020-05-06       Impact factor: 3.561

5.  Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.

Authors:  Edward Kumakech; Vanja Berggren; Henry Wabinga; Gabriella Lillsunde-Larsson; Gisela Helenius; Malin Kaliff; Mats Karlsson; Samuel Kirimunda; Caroline Musubika; Sören Andersson
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

6.  Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.

Authors:  Sheona M Mitchell; Heather N Pedersen; Evelyn Eng Stime; Musa Sekikubo; Erin Moses; David Mwesigwa; Christine Biryabarema; Jan Christilaw; Josaphat K Byamugisha; Deborah M Money; Gina S Ogilvie
Journal:  BMC Womens Health       Date:  2017-01-13       Impact factor: 2.809

7.  Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.

Authors:  Nicole G Campos; Mercy Mvundura; Jose Jeronimo; Francesca Holme; Elisabeth Vodicka; Jane J Kim
Journal:  BMJ Open       Date:  2017-06-15       Impact factor: 2.692

8.  The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries.

Authors:  Megan J Huchko; May Maloba; Miriam Nakalembe; Craig R Cohen
Journal:  J Int AIDS Soc       Date:  2015-12-01       Impact factor: 5.396

9.  Strategies for Community Education Prior to Clinical Trial Recruitment for a Cervical Cancer Screening Intervention in Uganda.

Authors:  Sheona M Mitchell; Heather N Pedersen; Musa Sekikubo; Christine Biryabarema; Josaphat J K Byamugisha; David Mwesigwa; Malcolm Steinberg; Deborah M Money; Gina S Ogilvie
Journal:  Front Oncol       Date:  2016-04-13       Impact factor: 6.244

10.  A tailored within-community specimen collection strategy increased uptake of cervical cancer screening in a cross-sectional study in Ghana.

Authors:  Adolf K Awua; Edwin K Wiredu; Edwin A Afari; Ahmad S Tijani; Gabriel Djanmah; Richard M K Adanu
Journal:  BMC Public Health       Date:  2017-08-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.